What is Anti-Phospholipid Syndrome?
Antiphospholipid syndrome (APS) is a systemic autoimmune disorder occurring worldwide, with an estimated prevalence of 40–60 per 100,000 individuals. Women are affected more frequently than men.
Whereas primary antiphospholipid syndrome (PAPS) occurs independently from other diseases, the more common secondary antiphospholipid syndrome (SAPS) is frequently related to other autoimmune diseases such as Systemic Lupus Erythematosus (SLE) or Rheumatoid Arthritis (RA). APS is characterized by the presence of antiphospholipid antibodies, which increase the risk of thrombosis and pregnancy complications.
In addition to classical criteria, non-criteria APS manifestations—including thrombocytopenia, heart valve disease, and neurological symptoms—are increasingly recognized. Non-criteria APS can also be associated with antibodies such as anti-phosphatidylserine, anti-prothrombin, anti-annexin V, and other emerging markers that help identify patients at risk.
Antiphospholipid syndrome can lead to serious consequences, including recurrent blood clots, pregnancy loss, organ damage, and long-term disability if not properly managed.
1 in 2,000
individuals are affected by APS
5:1
is the women-men affected ratio
15%
of recurrent pregnancy losses are related to APS
How do we diagnose APS?
The diagnosis of APS is based on the clinical symptoms and confirmed by laboratory methods. Laboratory confirmation of APS is generally performed by the determination of antibodies against phospholipids and phospholipid binding proteins. Although a range of different test systems based on various methods has been made available, the use of standardized ELISA-based immunoassays is recommended in the latest ACR / EULAR APS classification criteria 2023.
Knowledge & Science
No content available.
Instruments for diagnosing Antiphospholipid Syndrome
Any assay, any sample, any time!
References
a) Barbhaiya et al. (2023) 2023 ACR/EULAR antiphospholipid syndrome classification criteria. Ann. Rheum. Dis. 82, 1258.
b) Volkov et al. (2020) Profiles of criteria and non-criteria anti-phospholipid autoantibodies are associated with clinical phenotypes of the antiphospholipid syndrome. Auto. Immun. Highlights. 11, 8.
c) Devreese et al. (2014) Testing for antiphospholipid antibodies with solid phase assays: guidance from the SSC of the ISTH. J. Thromb. Haemost. 12, 792.
This section contains information intended for wide distribution and may therefore contain product details or information that is not available or valid in your country. Please contact your local Sebia representative. Information intended for healthcare professionals. Carefully read the instructions in the reagent package inserts and instrument manuals.